By Katherine Gombay, McGill Newsroom Discovery opens door to development of new drugs to control weight gain and obesity It’s rare for scientists to get what they describe as “clean” results without spending a lot of time repeating the same experiment over and over again. But when researchers saw the mice they were working with doubling their weight within a month or two, they knew they were on to something.
May 2016 - Multiple Sclerosis Awareness Month Multiple sclerosis treatment and research has long been a focus at the Montreal Neurological Institute and Hospital, known simply as The Neuro, an illustrious member of McGill University and the McGill University Health Centre. Indeed, The Neuro introduced Canada’s first MS clinic. The clinic’s highly specialized staff employs the latest research data and treatment methods in a clinical atmosphere of innovation and progress.
Un expert québécois soignera les plaies des centaines de victimes des attentats de Paris aux prises avec un syndrome de stress post-traumatique. La méthode du Montréalais Alain Brunet, spécialiste en traumatismes, sera utilisée dans 14 hôpitaux parisiens auprès de plus de 400 patients. La Presse Partie 1 Partie 2
McGill Newsroom Discovery offers hope for more effective treatments of deadly glioblastomas A gene known as OSMR plays a key role in driving the growth of glioblastoma tumors, according to a new study led by a McGill University researcher and published in the journal Nature Neuroscience.
The potential of light as a non-invasive, highly-focused alternative to pain medication was made more apparent thanks to research conducted by scientists at the Montreal Neurological Institute and Hospital of McGill University and the McGill University Health Centre.
Scientists at the Montreal Neurological Institute and Hospital -The Neuro, at McGill University and the McGill University Health Centre, have made a breakthrough in understanding an important protein that appears to act as a kind of cellular “marriage broker.” The protein called Netrin1 brings cells together and maintains their healthy relationships. Netrin1 plays an essential role in the growth of the human organism, directing cell migration and the formation of cell circuits both at the embryo stage and after birth.
Discovery provides new tool for understanding and treating neurodegenerative diseases
Researchers get inaugural Foundation grants for high-impact, long-term programs Researchers from the Montreal Neurological Institute and Hospital, McGill University have been awarded over $15 million in grants in the latest round of funding by the Canadian Institutes of Health Research (CIHR). The grants are part of over $600 million in national funding, announced July 28 by Minister of Health Rona Ambrose.
Study fuels nature versus nurture debate How do you get to Carnegie Hall? New research on the brain’s capacity to learn suggests there’s more to it than the adage that “practise makes perfect.” A music-training study by scientists at the Montreal Neurological Institute and Hospital -The Neuro, at McGill University and colleagues in Germany found evidence to distinguish the parts of the brain that account for individual talent from the parts that are activated through training.
New research released today in Nature Neuroscience reveals for the first time that pain is processed in male and female mice using different cells. These findings have far-reaching implications for our basic understanding of pain, how we develop the next generation of medications for chronic pain—which is by far the most prevalent human health condition—and the way we execute basic biomedical research using mice.
Time is brain: for every minute a stroke is left untreated, 2 million brain cells are destroyed. The sooner patients are treated, the higher the chances of survival with fewer disabilities. Patients with acute strokes and transient ischemic attack (TIA) are assessed and treated at the right place, the right time and by the right professionals thanks to ultra-specialized stroke centres at the Montreal General Hospital and The Montreal Neurological Institute and Hospital.
Researchers from the Montreal Neurological Institute and Hospital at McGill University and the MUHC, have received a total of over $4.5 M in funding, for innovative projects to accelerate diagnosis and drug discovery for diseases of the brain, including Alzheimer’s. CQDM, Brain Canada Foundation and the Ontario Brain Institute made the announcement at the annual conference of the Canadian Association for Neuroscience in Vancouver. Six Canadian research teams share a total investment of $ 10 million, through the strategic "Focus on Brain" initiative.
Researchers pinpoint a brain area that influences electoral decisions
As a major Canadian centre for amyotrophic lateral sclerosis (ALS) research and treatment, the Montreal Neurological Institute and Hospital - The Neuro, invites the public and the media to learn more about the disease and current research and treatments, to donate money for ALS research and to wear the national emblem of ALS in Canada, the blue cornflower, during ALS Awareness Month in June.
Today the Honourable Ed Holder, Minister of State (Science and Technology) announced an investment of $333 million for research infrastructure through the Canada Foundation for Innovation (CFI). Two projects submitted by researchers affiliated with the Montreal Neurological Institute and Hospital – The Neuro at McGill University and the MUHC, have received a total of over $21 M in funding, with matching funds from the Government of Quebec.